MedTrace Logo

Resistance Exercise, Muscle Mass, Strength and Body Composition

NCT01766791 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2014-03-21

No results posted yet for this study

Summary

A plethora of trials reported the positive effect of resistance exercise on functional and morphological parameters. Although a large amount of the studies used suboptimum devices and obsolete methods the results of these older studies were still considered as golden standard. The aim of the present study is thus to determine the proper effect of different resistance exercise protocols with and without adjuvant protein supplementation on functional and morphological muscle and body composition parameters in male untrained subjects 30-50 years old under special regard of modern medical imaging and segmentation technologies.

Our general study hypothesis is that HIT-resistance exercise significantly impact relevant muscular parameters of the upper leg.

Conditions

Interventions

OTHER

HIT-exercise, low repetition range

High Intensity Resistance Exercise Training, low repetition range, \> 75% 1RM

OTHER

HIT-exercise, high repetition range

High Intensity Resistance Exercise Training, high repetition range, 60 - \< 75 1RM

OTHER

HIT-exercise with protein

High Intensity Resistance Exercise Training, low repetition range, \> 75% 1RM and Protein Supplementation

OTHER

Control

control group, no intervention, maintenance of physical activity

Sponsors & Collaborators

  • Klinikum Nürnberg

    collaborator OTHER

  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Principal Investigators

  • Wolfgang Kemmler, PhD · University of Erlangen-Nürnberg Medical School

  • Andreas Wittke, MA · University of Erlangen-Nürnberg Medical School

  • Klaus Engelke, PhD · University of Erlangen-Nürnberg Medical School

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
30 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01766791 on ClinicalTrials.gov